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COVID-19 is a new form of Coronavirus disease due to 
the novel virus SARS-CoV2 that causes acute infection 
with respiratory symptoms. The virus is most commonly 
spread via respiratory route which requires close person 
to person contact (within 6 feet). Transmission may also 
occur if a person touches a surface or object that has the 
virus on it and then touches their own mouth, nose, or 
possibly their eyes. On March 9, 2020, Michigan became 
the latest state to report case(s) of COVID-19. On March 
11, the WHO also officially declared COVID-19 a pandemic 
(sustained and continuous transmission of the disease, 
simultaneously in more than three different geographical 
regions). Pandemic does not refer to the lethality of 
a virus but to its transmissibility and geographical 
extension.
 Although initial screening efforts were limited to persons 
with symptoms and specific risk factors, including travel 
to countries such as South Korea, Japan, Italy, Iran and 
China, the CDC has liberalized testing criteria as testing 
kits have become more widely available and incidence 
of community spread increased. Specifically, clinicians 
should use their judgement to determine if a patient 
has signs and symptoms compatible with COVID-19 and 
whether the patient should be tested. Decisions on which 
patients receive testing should be based on the local 
epidemiology of COVID-19, as well as the clinical course of 
illness (cdc.gov).
Clinical Presentation
Coronaviruses are a large family of zoonotic viruses that 
can be transmitted to humans via animal intermediaries. 
Seven (beta) species, including the new species dubbed 
COVID-19 (aka SARS-CoV-2) are known to cause human 
infection. Four of them typically cause mild disease 
in immunocompetent individuals. The other 3 species 
can cause more severe disease: SARS-CoV which was 
implicated in 2002 and 2003 outbreaks in Guangdong, 
China and MERS-CoV (which emerged in 2012 in the 
Middle East) and the newest COVID-19 can cause severe 
illness and fatalities.
While many patients with confirmed COVID-19 infection 
develop fever and/or signs of respiratory illness such as 
cough and shortness of breath, most patients are either 
asymptomatic or only mildly ill. Asymptomatic patients 
are capable of spreading infection. Incubation period 
appears to range between two days to up to two weeks 
following exposure. Morbidity and mortality increase 
dramatically in patients >60 and/or with pre-existing 
medical co-morbidities such as heart disease, lung 
disease and diabetes. As yet, no vaccine or specific drugs 
exist to prevent or treat infection; however, clinical 
trials for putative vaccines and anti-viral therapy are 
underway.
Fast action is key to minimizing coronavirus impact 
both to slow the spread of the virus and also ensure that 
healthcare systems aren’t overwhelmed. Respiratory 
health professionals, in particular, will be at the forefront 
of dealing with the outbreak, helping to contain and 
mitigate the spread, treating patients and preventing 
public panic.
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As of March 9, 2020, globally there are 
109,577 confirmed cases of  
COVID-19, and 3809 deaths.  
Of those cases, 80,904 cases and 3123 
deaths are in China. Outside of China, 
there are 28,673 confirmed cases and 686 
deaths in 104 countries, including the US. 
This situation is rapidly evolving and the 
reported number of confirmed cases and 
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Prevention of Infection, Exposure and Spread
	■ Handwashing with soap and water for at least 20 
seconds is the most effective way to minimize exposure. 
If soap and water are not available, use an alcohol-based 
(minimum 60%) hand sanitizer.
	■ Avoid touching eyes, nose, and mouth with unwashed 
hands. 
	■ Social distancing, avoid crowds and group events, stay 6 
feet away from other people.
	■ Avoid close contact with people who are sick.
	■ Cover cough or sneeze with a tissue, then discard the 
tissue in a contained trash.
	■ Clean and disinfect frequently touched objects and 
surfaces. The virus can be effectively inactivated from 
surfaces with a solution of either ethanol (62-71% 
alcohol), hydrogen peroxide (0.5% hydrogen peroxide) 
or sodium hypochlorite (0.1% bleach) in just one minute.
	■ Well people are not advised to wear facemasks at this 
time.
	■ Call your physician if you believe you have been exposed 
and have symptoms. In particular, stay home if you are 
well or have minimal symptoms.
Reporting, Testing, and Specimen Collection
Submission procedures for specimen testing has been 
simplified, though there are still places that require prior 
approvals. Testing is becoming more widely available 
everyday. Many public health laboratories and some 
private laboratories, are now testing for SARS-CoV-2. 
Some hospital labs, especially at major academic medical 
centers, are also capable of performing in-house testing. 
For initial diagnostic testing for SARS-CoV-2, CDC 
recommends collecting and testing upper respiratory tract 
specimens (nasopharyngeal AND oropharyngeal swabs). 
While lower respiratory samples (e.g sputum and BAL) can 
also be submitted, sputum induc tion is not necessary and 
should not be done. Bronchoscopy for BAL sample is not 
encouraged due to concern of aerosolizing the virus.
Respiratory specimen storage and transport instructions 
are available from CDC at https://www.cdc.gov/
coronavirus/ 
2019-nCoV/lab/guidelines-clinical-specimens.html. 
Notify infection control personnel at your healthcare 
facility and your state or local health department if you 
have a patient who is classified as a PUI for COVID-19
Treatment
No specific antiviral treatment is recommended for the 
COVID-19 infection, though clinical trials are underway for 
antiviral therapy. Symptomatic and supportive care are 
recommended along with respiratory and contact isolation 
for infected individuals. 
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• The National Ebola Training and Education Center (NETEC) 
has a great video on the use of coronavirus PPE including 
proper donning and doffing. Entire video is 18 minutes long. 
Section on actual use of PPE starts at around 4 minutes. 
https://www.youtube.com/watch?v=bG6zISnenPg
R Action Steps
In addition to reporting suspected cases to the CDC, we 
encourage providers to:
 ✔ Use their judgment to determine if a patient has signs and 
symptoms compatible with COVID-19 and whether the 
patient should be tested especially if there has been recent 
travel from China (except Taiwan and Macau), Japan, South 
Korea, Japan, Italy, Iran or other areas where community 
spread is occurring, or exposure to close contact with a 
laboratory-confirmed COVID-19 patient.
• Patients should be encouraged to stay home if they have 
no or minimal symptoms
• Patients sick enough to warrant in-person evaluation 
should be directed to a medical facility with Airborne 
(negative pressure room) and Contact Precaution available 
(personal protective equipment (e.g., gowns, gloves, 
NIOSH-certified disposable N95 respirator, eye protection).
 ✔ Inform infection control and local health department of 
suspected cases.
 ✔ Isolate respiratory specimens (nasopharyngeal and 
oropharyngeal swabs) and send per protocol for suspected 
COVD-19 infection to CDC, hospital,  public health or private 
lab that is equipped to conduct this testing.
 
